
    
      Primary objectives :

      To define the dose-limiting toxicity and maximum tolerated dose in phase I study To evaluate
      the overall response rate in phase II study

      Secondary objectives :

        1. To evaluate the safety and tolerability of the treatment combination.

        2. To estimate overall survival.

        3. To estimate the time to progression and the duration of overall response.
    
  